Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011

Area of Science:

• Hematology
• Oncology

Background:

• Chronic Lymphocytic Leukaemia (CLL) remains largely incurable.
• Optimal treatment strategies for various CLL patient subgroups are still under investigation.
• The Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) CLL Working Party develops guidelines.

Purpose of the Study:

• To summarize revised guidelines for the diagnosis and treatment of CLL.
• To highlight the importance of enrolling CLL patients in clinical trials.
• To present current studies initiated by the HOVON CLL working party.

Main Methods:

• Review and summarization of updated CLL diagnostic and treatment guidelines.
• Emphasis on the rationale for clinical trial participation in CLL management.
• Overview of ongoing HOVON CLL working party-initiated clinical studies.

Main Results:

• Revised guidelines for CLL diagnosis and treatment are presented.
• Despite advances, CLL remains incurable for most patients.
• The need for treating patients within clinical studies is reinforced.

Conclusions:

• Updated guidelines provide current recommendations for CLL diagnosis and treatment.
• Enrollment in clinical studies is crucial for advancing CLL care and addressing treatment uncertainties.
• HOVON CLL working party continues to drive research through initiated clinical studies.